Stay updated with breaking news from Achieved Second Quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Achieved Second Quarter 2023 Total Revenue of $37.6 Million and U.S. XPOVIO® (selinexor) Net Product Revenue of $28.5 Million – – Maintains Full Year 2023...
Achieved Second Quarter 2023 Total Company Average Production of Approximately 33,800 BOPD, an Increase of 7% from First Quarter 2023 2023 Year-to-Date Total
Achieved Second Quarter 2023 Total Company Average Production of Approximately 33,800 BOPD, an Increase of 7% from First Quarter 20232023 Year-to-Date Total Company Average Production1 of Approximately 32,900 BOPDTotal
Achieved Second Quarter 2023 Total Company Average Production of Approximately 33,800 BOPD, an Increase of 7% from First Quarter 20232023 Year-to-Date...
Achieved Second Quarter 2023 Total Company Average Production of Approximately 33,800 BOPD, an Increase of 7% from First Quarter 20232023 Year-to-Date Total Company Average Production1 of...